These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22150819)

  • 1. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment.
    Holland R; Matheson C; Anthony G; Roberts K; Priyardarshi S; Macrae A; Whitelaw E; Appavoo S; Bond C
    Drug Alcohol Rev; 2012 Jun; 31(4):483-91. PubMed ID: 22150819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
    Holland R; Maskrey V; Swift L; Notley C; Robinson A; Nagar J; Gale T; Kouimtsidis C
    Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review.
    McNair R; Monaghan M; Montgomery P
    Drug Alcohol Depend; 2023 Jun; 247():109869. PubMed ID: 37086659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.
    Groshkova T; Metrebian N; Hallam C; Charles V; Martin A; Forzisi L; Lintzeris N; Strang J
    Drug Alcohol Rev; 2013 Nov; 32(6):566-73. PubMed ID: 24118500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
    Belcher AM; Cole TO; Greenblatt AD; Hoag SW; Epstein DH; Wagner M; Billing AS; Massey E; Hamilton KR; Kozak ZK; Welsh CJ; Weintraub E; Wickwire EM; Wish ED; Kaptchuk TJ; Colloca L
    BMJ Open; 2019 Jun; 9(6):e026604. PubMed ID: 31230007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Chawarski MC; Zhou W; Schottenfeld RS
    Drug Alcohol Depend; 2011 Jun; 115(3):237-9. PubMed ID: 21159452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METODO, a prospective observational study to assess the efficacy and tolerability of methadone in heroin-addicted patients undergoing a methadone maintenance treatment: preliminary results at baseline evaluation.
    D'Egidio PF; Bignamini E; De Vivo E; Leonardi C; Pieri MC; González-Saiz F; Lucchini A;
    Subst Use Misuse; 2013 Dec; 48(14):1530-40. PubMed ID: 23822738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.
    Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J
    Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regaining control: the patient experience of supervised compared with unsupervised consumption in opiate substitution treatment.
    Notley C; Holland R; Maskrey V; Nagar J; Kouimtsidis C
    Drug Alcohol Rev; 2014 Jan; 33(1):64-70. PubMed ID: 24256157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.
    Kakko J; Svanborg KD; Kreek MJ; Heilig M
    Lancet; 2003 Feb; 361(9358):662-8. PubMed ID: 12606177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
    Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S
    Addiction; 2000 Nov; 95(11):1631-45. PubMed ID: 11219367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone prescribing under supervised consumption on premises: a Scottish clinician's perspective on prescribing practice.
    Anthony GB; Matheson CI; Holland R; Bond C; Roberts K; Rae AM; Whitelaw E; Priyadarshi S
    Drug Alcohol Rev; 2012 May; 31(3):342-7. PubMed ID: 21726308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial.
    Jaffray M; Matheson C; Bond CM; Lee AJ; McLernon DJ; Johnstone A; Skea L; Davidson B
    Int J Pharm Pract; 2014 Feb; 22(1):4-12. PubMed ID: 23822820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
    Bond AJ; Reed KD; Beavan P; Strang J
    Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.